… It was set up to investigate risk factors in ischemic heart disease and to identify those
explaining the difference in CHD incidence between France and Northern Ireland. From 1991 to …

Van Tassell et al IL-1 and Heart Disease 1911 progression of coronary artery disease and
impaired function. Nevertheless, reports of an inflammatory response during heart disease …

… have focused on treatments for pediatric congenital heart disease (CHD). There are … cells
in culture. Therefore, we began to explore the potential of using alternative cell types and cell …

… Not all types of cell-based preparations necessarily include stem cells and the field may
be … termed cell-based therapy rather than stem cell therapy. Clinical trials testing cellular …

… such as hematocrit, white blood cell count, and their subtypes, are associated with coronary
heart disease and can improve our ability to predict coronary heart disease risk [49]. Several …

… The cells are numerous and distribute throughout the body to take up residence in many …
mere hours during disease. Typically, we study tissue macrophages by staining for cell surface …

… The Framingham Heart Study in the 1980s demonstrated that the risk of coronary heart
disease (CHD) was significantly lower among persons with higher levels of high-density …

… -α therapies are described where applicable. The postulated role of TNF-α signaling
concerning innate cardiac cellular processes that may have direct adaptive effects in the heart will …

… Few studies have reported whether sex affects the properties of MSCs or whether female
or male patients gain more benefits from stem cell therapy. The functional characteristics and …

… , administration of AdVEGF121 by direct intramyocardial injections resulted in objective
improvement in exercise-induced ischemia in patients with refractory ischemic heart disease. …